Literature DB >> 14232179

THE ROLE OF THE ANAESTHETIST IN A DIAGNOSTIC MYASTHENIA GRAVIS CLINIC.

L C JENKINS, J CHANG, L ZELDOWICZ, W J BUCKLER, H B GRAVES.   

Abstract

Keywords:  CURARIFORM ANTAGONISTS; DECAMETHONIUM COMPOUNDS; EDROPHONIUM CHLORIDE; ELECTROMYOGRAPHY; MYASTHENIA GRAVIS; NEOSTIGMINE; PHARMACOLOGY

Mesh：

Substances：

Year:  1964        PMID： 14232179     DOI： 10.1007/bf03004108

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN： 0008-2856


× No keyword cloud information.
  6 in total

1.  Myasthenia gravis: A guide for anesthesiologists.

Authors:  F F FOLDES; P G McNALL
Journal:  Anesthesiology       Date:  1962 Nov-Dec       Impact factor: 7.892

2.  Alterations in neuromuscular transmission in myasthenia gravis as determined by studies of drug action.

Authors:  D GROB; R J JOHNS; A M HARVEY
Journal:  Am J Med       Date:  1955-11       Impact factor: 4.965

3.  Neuromuscular transmission in myasthenia gravis.

Authors:  H C CHURCHILL-DAVIDSON; A T RICHARDSON
Journal:  J Physiol       Date:  1953-11-28       Impact factor: 5.182

4.  The action of decamethonium iodide (C.10) in myasthenia gravis.

Authors:  H C CHURCHILL-DAVIDSON; A T RICHARDSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1952-05       Impact factor: 10.154

5.  The action of decamethonium on normal and denervated mammalian muscle.

Authors:  E J ZAIMIS
Journal:  J Physiol       Date:  1951-01       Impact factor: 5.182

6.  Decamethonium iodide (c 10); some observations on its action using electromyography.

Authors:  H C CHURCHILL-DAVIDSON; A T RICHARDSON
Journal:  Proc R Soc Med       Date:  1952-04
  6 in total
  1 in total

1.  Myasthenia gravis: comparative evaluation of medical and surgical treatment.

Authors:  L R Zeldowicz; G D Saxton
Journal:  Can Med Assoc J       Date:  1969-11-15       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.